Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of subcutaneous glucagon around exercise in type 1 diabetes
2016-002127-28Phase 4Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- May 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of glucagon in diabetes mellitus type 1 (T1D) (3 arms), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: Peak plasma glucose within 2 hours after glucagon injection. Started May 2016; status: completed.
02
Drugs
glucagon
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2016-002127-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002127-28.